| Abbott Laboratories |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| AstraZeneca |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Bayer Heaalthcare |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Bristol-Myers Squibb |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Eli Lilly |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Johnson & Johnson |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Merck |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Novartis |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Pfizer |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Roche |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| Sanofi |
Abstract
|
|
Heather Cartwright, Taskin Ahmed |
|
| AstraZeneca Ramps Up Deal-Making Activity |
Abstract
|
|
Heather Cartwright |
|